Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis

Advances in Experimental Medicine and Biology

Volumn 756, Issue , 2013, Pages 147-153

  Lewandowska, K ^a   Ciurzynski, M ^a   Gorska, E ^a   Bienias, P ^a   Irzyk, K ^a   Siwicka, M ^a   Zycinska, K ^a   Pruszczyk, P ^a   Demkow, U ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Anti endothelial cell antibodies; Interstitial lung disease; Pulmonary fibrosis; Pulmonary hypertension; Systemic scleroderma

Indexed keywords

ENDOTHELIAL CELL ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84867511454     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4549-0_19     Document Type: Conference Paper

References (26)

1. Abraham, D. J., & Varga, J. (2005). Scleroderma: From cell and molecular mechanisms to disease models. Trends in Immunology, 26 (11), 587-595.
2. Ahmed, S. S., Tan, F. K., Arnett, F. C., Jin, L., & Geng, Y. J. (2006). Induction of apoptosis and fi brillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis and Rheumatism, 54 (7), 2250-2262.
3. Belizna, C., & Tervaert, J. W. (1997). Speci fi city, pathogenicity, and clinical value of antiendothelial cell antibodies. Seminars in Arthritis and Rheumatism, 27 (2), 98-109.
4. Ciurzynski, M., Bienias, P., Irzyk, K., Rymarczyk, Z., Kostrubiec, M., Szewczyk, A., Glinska-Wielochowska, M., Zylkowska, J., Kurzyna, M., & Pruszczyk, P. (2011). Usefulness of echocardiography in the identi fi cation of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis. Kardiologia Polska, 69 (1), 9-15.
5. Del Papa, N., Quirici, N., Scavullo, C., Gianelli, U., Corti, L., Vitali, C., Ferri, C., Giuggioli, D., Manfredi, A., Maglione, W., Onida, F., Colaci, M., Bosari, S., & Lambertenghi Deliliers, G. (2010). Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. The Journal of Rheumatology, 37 (10), 2053-2063.
6. Grandtnerova, B., Mackova, N., Hovoricova, B., & Jahnova, E. (2008). Hyperacute rejection of living related kidney grafts caused by endothelial cell-speci fi c antibodies: Case reports. Transplantation Proceedings, 40 (7), 2422-2424.
7. Guiducci, S., Giacomelli, R., & Cerinic, M. M. (2007). Vascular complications of scleroderma. Autoimmunity Reviews, 6 , 520-523.
8. Guilpain, P., & Mouthon, L. (2008). Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases. Clinical Reviews in Allergy & Immunology, 35 (1-2), 59-65.
9. Hummers, L. K. (2008). Biomarkers of vascular disease in scleroderma. Rheumatology (Oxford, England), 47 (Suppl 5), v21-v22.
10. Katritsis, D. G., Zografos, T., Korovesis, S., Giazitzoglou, E., Youinou, P., Skopouli, F. N., & Moutsopoulos, H. M. (2010). Antiendothelial cell antibodies in patients with coronary artery ectasia. Coronary Artery Disease, 21 (6), 352-356.
11. Konttinen, Y. T., Mackiewicz, Z., Ruuttila, P., Ceponis, A., Sukura, A., Povilenaite, D., Hukkanen, M., & Virtanen, I. (2003). Vascular damage and lack of angiogenesis in systemic sclerosis skin. Clinical Rheumatology, 22 , 196-202.
12. Magro, C. M., Waldman, W. J., Knight, D. A., Allen, J. N., Nadasdy, T., Frambach, G. E., Ross, P., & Marsh, C. B. (2006). Idiopathic pulmonary fi brosis related to endothelial injury and antiendothelial cell antibodies. Human Immunology, 67 (4-5), 284-297.
13. Maricq, H. R., Downey, J. A., & LeRoy, E. C. (1976). Standstill of nailfold capillary blood fl ow during cooling in scleroderma and Raynaud's syndrome. Blood Vessels, 13 , 338-349.
14. Mihai, C., & Tervaert, J. W. (2010). Anti-endothelial cell antibodies in systemic sclerosis. Annals of the Rheumatic Diseases, 69 (2), 319-324.
15. Müller-Ladner, U., Distler, O., Ibba-Manneschi, L., Neumann, E., & Gay, S. (2009). Mechanisms of vascular damage in systemic sclerosis. Autoimmunity, 42 (7), 587-595.
16. Nagai, Y., Yamanaka, M., Hashimoto, C., Nakano, A., Hasegawa, A., Tanaka, Y., Yokoo, H., Nakazato, Y., & Ishikava, O. (2007). Autopsy case of systemic sclerosis with severe pulmonary hypertension. The Journal of Dermatology, 34 , 769-772.
17. Norton, W. L., & Nardo, J. M. (1970). Vascular disease in progressive systemic sclerosis (scleroderma). Annals of Internal Medicine, 73 , 317-324.
18. Orfanos, S. E., Psevdi, E., Stratigis, N., Langleben, D., Catravas, J. D., Kyriakidis, M., Moutsopoulos, H. M., Roussos, C., & Vlachoyiannopoulos, P. G. (2001). Pulmonary capillary endothelial dysfunction in early systemic sclerosis. Arthritis and Rheumatism, 44 , 902-911.
19. Papadopoulos, D. P., Makris, T. K., Krespi, P., Papazachou, U., Stavroulakis, G., Hatzizacharias, A., & Votteas, V. (2006). Antiendothelial cell antibody levels in healthy normotensives with high normal blood pressure. Clinical and Experimental Hypertension, 28 (8), 663-667.
20. Revelen, R., D'Arbonneau, F., Guillevin, L., Bordron, A., Youinou, P., & Dueymes, M. (2002). Comparison of cell-ELISA, fl ow cytometry and Western blotting for the detection of antiendothelial cell antibodies. Clinical and Experimental Rheumatology, 20 (1), 19-26.
21. Salerni, R., Rodnan, G. P., Leon, D. F., & Shaver, J. A. (1977). Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Annals of Internal Medicine, 86 , 394-399.
22. Servettaz, A., Guilpain, P., Camoin, L., Mayeux, P., Broussard, C., Tamby, M. C., Tamas, N., Kaveri, S. V., Guillevin, L., & Mouthon, L. (2008). Identi fi cation of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach. Proteomics, 8 (5), 1000-1008.
23. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. (1980). Preliminary criteria for the classi fi cation of systemic sclerosis. Arthritis and Rheumatism, 23 , 581-590.
24. Wigley, F. M. (2009). Vascular diseases in scleroderma. Clinical Reviews in Allergy & Immunology, 36 (2-3), 150-175.
25. Yoshio, T. (2001). Antiendothelial cell antibodies and their relation to pulmonary hypertension in connective tissue diseases. Nihon Rinsh? Men'eki Gakkai Kaishi, 24 (4), 133-141.
26. Zielonka, T. M., Demkow, U., Radzikowska, E., Bialas, B., Filewska, M., Zycinska, K., Obrowski, M. H., Kowalski, J., Wardyn, K. A., & Skopinska-Rozewska, E. (2010). Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function. European Journal of Medical Research, 15 (Suppl 2), 229-234.